The S&P 500 opened flat as experts analyzed the Covid-19 vaccine
The US health agency is calling for a pause of the Johnson and Johnson coronavirus vaccine rollout while investigating reports of blood clots.
Despite the news, the S&P 500 opened in the flat on Tuesday a few days after solid profits at the US index.
– Advertising –
The S&P 500 was 0.05% higher at 4,130.10, while Nasdaq composites rose 0.38% at the opening bell to 13,902.45.
The Centers for Disease Control and Prevention and the Food and Drug Administration issued a joint statement on Tuesday. It said it is examining six reported cases in the US of “rare and severe” blood clots in Johnson and those receiving the Johnson vaccine.
All of the people involved were women between the ages of 18 and 48 and developed symptoms 6-13 days after receiving the vaccine.
Dosages of just under 7m are being administered across the United States.
The CDC will hold an Advisory Committee meeting on Vaccination Practices on Wednesday where it will review the incident, but the FDA will also investigate the nature of the blood clots.
“We recommend that you suspend use of this vaccine from a wealth of caution until the process is complete,” they said, but Johnson and Johnson, along with related health organizations, are associated with data. We have confirmed that we are continuing to analyze the following.
“We are aware that thromboembolic events, including those with thrombocytopenia, have been reported in the Covid-19 vaccine. Currently, it is clear between these rare events and the Janssen Covid-19 vaccine. No causal relationships have been established.”
